IRIS
NIEDDU, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 642
EU - Europa 354
AS - Asia 134
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 1.139
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 640
UA - Ucraina 124
CN - Cina 108
IT - Italia 96
DE - Germania 48
FR - Francia 35
FI - Finlandia 21
TR - Turchia 17
BE - Belgio 8
GB - Regno Unito 7
AU - Australia 4
GR - Grecia 4
SE - Svezia 3
BR - Brasile 2
CA - Canada 2
EU - Europa 2
HR - Croazia 2
IN - India 2
JP - Giappone 2
IM - Isola di Man 1
LU - Lussemburgo 1
NL - Olanda 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PL - Polonia 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VN - Vietnam 1
Totale 1.139
Salva come PNG Salva come JPEG
Città #
Chandler 203
Jacksonville 79
New York 57
Princeton 52
Sassari 43
Nanjing 30
Ann Arbor 29
Dearborn 24
Wilmington 22
Izmir 14
Beijing 12
Changsha 12
Nanchang 11
Brussels 8
Tianjin 7
Villiers-sur-marne 7
Hebei 6
Mountain View 6
Shenyang 6
Ashburn 5
Boardman 5
Cagliari 5
Hangzhou 5
Woodbridge 5
Helsinki 4
Jiaxing 4
Ningbo 4
Pátrai 4
Zhengzhou 4
Melbourne 3
Oristano 3
San Francisco 3
Auburn Hills 2
Fairfield 2
Kunming 2
Norwalk 2
Porto Torres 2
Serramanna 2
Taizhou 2
Toronto 2
Zagreb 2
Adelaide 1
Amsterdam 1
Andover 1
Bangkok 1
Bratislava 1
Cedar Knolls 1
Changchun 1
Chernihiv 1
Città Di Castello 1
Cupertino 1
Denver 1
Douglas 1
Hanoi 1
Hanover 1
Harrow 1
Jinan 1
Kathmandu 1
Lanzhou 1
London 1
Los Angeles 1
Luxembourg 1
New Plymouth 1
Oslo 1
Potenza 1
Quezon 1
Rome 1
San Jose 1
Santa Clara 1
Seattle 1
Secaucus 1
Singapore 1
Sinnai 1
São Paulo 1
Tappahannock 1
Tokyo 1
Warsaw 1
Totale 736
Salva come PNG Salva come JPEG
Nome #
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 73
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 72
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 63
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 61
Glycosaminoglycan functionalization of electrospun scaffolds enhances Schwann cell activity 57
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 53
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 52
HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo 51
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 50
Identification and characterization of biomarkers in atherosclerosis and diabetes. 49
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 44
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 41
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 39
A Collagen-GAG synthetic extracellular matrix entrapped into PLLA polymeric scaffolds. 38
Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes 37
Urine bikunin as a marker of renal impairment in Fabry's disease 35
Collagenic architecture and morphotraits in a marine basal metazoan as a model for bioinspired applied research 34
QUANTITATIVE AND STRUCTURAL ANALYSES OF URINARY TRYPSIN INHIBITOR IN TYPE 1 AND TYPE 2 DIABETES 33
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 30
Urine Bikunin Quantitation and Structural Characterization in Type I and Type II Diabetes Patients 28
Identification and characterization of biomarkers in atherosclerosis and diabetes 27
Apolipoprotein signature of hdl and ldl from atherosclerotic patients in relation with carotid plaque typology: A preliminary report 27
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 27
Proteomic analysis of plasma-purified VLDL, LDL and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 25
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease 24
Morphological and biochemical traits of target marine sponges 20
Glycosaminoglycans: From Vascular Physiology to Tissue Engineering Applications 19
Circulating Proteoglycans/Glycosaminoglycans as Cancer Biomarkers 16
Purification of an Acidic Polysaccharide with Anticoagulant Activity from the Marine Sponge Sarcotragus spinosulus 13
A Method for Urinary Trypsin Inhibitor (UTI) Purification Combining Anion-Exchange Chromatography Enrichment and Preparative SDS-PAGE 12
Molecular Characterization of Plasma HDL, LDL, and VLDL Lipids Cargos from Atherosclerotic Patients with Advanced Carotid Lesions: A Preliminary Report 10
Molecular and pathobiological insights of bikunin/UTI in cancer 7
Searching for Atherosclerosis Biomarkers by Proteomics: A Focus on Lesion Pathogenesis and Vulnerability 6
Totale 1.173
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.271
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.271
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201938 0 0 0 0 0 0 0 0 0 0 1 37
2019/2020222 64 1 19 5 23 22 27 2 21 15 23 0
2020/2021151 22 1 23 3 22 1 22 2 29 25 1 0
2021/2022165 16 1 2 7 5 0 4 6 35 12 21 56
2022/2023341 29 40 8 53 44 45 0 51 43 5 18 5
2023/2024139 13 11 1 5 35 42 1 10 9 11 1 0
Totale 1.173